Feb 28, 2025 / 08:00AM GMT
Kari Krogstad - Medistim ASA - President, Chief Executive Officer
Good morning, everyone, and welcome to Medistim's Fourth Quarter and the Full Year 2024 Preliminary Financial Results. My name is Kari Krogstad. And together with my good colleague, CFO, Thomas Jakobsen, we will take you through the results.
First of all, I would like to remind everybody that Medistim's goal and ambition remains to deliver profitable growth consistently over time. And our track record shows that we have succeeded to deliver on this promise over the years.
But let's move into the fourth quarter. So I'm very pleased to being able to report an all-time high sales for a quarter, ending at NOK151.1 million, that is an 11.4% increase over the same quarter last year. And as we can see here, the currency effect is quite modest, and that means that the currency-neutral sales is also close to 10%. We can see that our third-party products is up 10% as well, meaning that we have good performance also from our own product sales, also close to 10%.
I would particularly point to Americas, which is really
Q4 2024 Medistim ASA Earnings Call Transcript
Feb 28, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers